These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. Arts N; Cané S; Hennequart M; Lamy J; Bommer G; Van den Eynde B; De Plaen E PLoS One; 2015; 10(4):e0122517. PubMed ID: 25853464 [TBL] [Abstract][Full Text] [Related]
45. CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma. Berico P; Cigrang M; Davidson G; Braun C; Sandoz J; Legras S; Vokshi BH; Slovic N; Peyresaubes F; Gene Robles CM; Egly JM; Compe E; Davidson I; Coin F EMBO Rep; 2021 Sep; 22(9):e51683. PubMed ID: 34296805 [TBL] [Abstract][Full Text] [Related]
46. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways. Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280 [TBL] [Abstract][Full Text] [Related]
47. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF. Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061 [TBL] [Abstract][Full Text] [Related]
48. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399 [TBL] [Abstract][Full Text] [Related]
49. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967 [TBL] [Abstract][Full Text] [Related]
50. MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells. Estrada C; Mirabal-Ortega L; Méry L; Dingli F; Besse L; Messaoudi C; Loew D; Pouponnot C; Bertolotto C; Eychène A; Druillennec S Commun Biol; 2022 Jan; 5(1):101. PubMed ID: 35091687 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP). Goswami S; Tarapore RS; Poenitzsch Strong AM; TeSlaa JJ; Grinblat Y; Setaluri V; Spiegelman VS J Biol Chem; 2015 Jan; 290(1):384-95. PubMed ID: 25414259 [TBL] [Abstract][Full Text] [Related]
52. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells. Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796 [TBL] [Abstract][Full Text] [Related]
53. The MITF family of transcription factors: Role in endolysosomal biogenesis, Wnt signaling, and oncogenesis. Ploper D; De Robertis EM Pharmacol Res; 2015 Sep; 99():36-43. PubMed ID: 26003288 [TBL] [Abstract][Full Text] [Related]
54. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells. Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685 [TBL] [Abstract][Full Text] [Related]
55. Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance. Ahmed F; Haass NK Front Oncol; 2018; 8():173. PubMed ID: 29881716 [TBL] [Abstract][Full Text] [Related]